Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Huang-Wei Xu"'
Autor:
Kao-Chi Chang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Yung-Yu Hsieh, Wei-Ming Chen, Yi-Hsing Chen, Chun-Hsien Chen, Chi-Wei Yen, Huang-Wei Xu, Wei-Lin Tung, Chao-Hung Hung, Sheng-Nan Lu, Te-Sheng Chang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Clinical trials showed pangenotypic direct-acting antivirals’ (DAAs) excellent efficacy and safety when treating hepatitis C virus (HCV). Two pangenotypic regimens were examined, glecaprevir/pibrentasvir (GLE/PIB) and sofosbuvir/velpatasvi
Externí odkaz:
https://doaj.org/article/c3f883780e4f498eae4652d3f293f1fe
Autor:
Chi-Ching Chen, Shui-Yi Tung, Kuo-Liang Wei, Chien-Heng Shen, Te-Sheng Chang, Wei-Ming Chen, Huang-Wei Xu, Chih-Wei Yen, Yi-Hsing Chen, Sheng-Nan Lu, Chao-Hung Hung
Publikováno v:
Journal of the Formosan Medical Association, Vol 119, Iss 1, Pp 532-537 (2020)
Background/Purpose: The major dose-limiting toxicity of ribavirin is hemolytic anemia. We investigated the incidence, risk factors and impact on virological response of anemia in chronic hepatitis C genotype 2 patients receiving sofosbuvir plus ribav
Externí odkaz:
https://doaj.org/article/13086ad5913a4056b336bce10fbc35cb
Autor:
Chun-Hsien Chen, Chien-Heng Shen, Kuo-Liang Wei, Huang-Wei Xu, Wei-Ming Chen, Kao-Chi Chang, Yu-Ting Huang, Yung-Yu Hsieh, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Publikováno v:
Diagnostics, Vol 13, Iss 3, p 473 (2023)
The findings regarding changes in renal function in patients with hepatitis C virus (HCV) infection treated with direct-acting antivirals (DAAs) are controversial. This study attempted to identify the factors associated with the large decline in rena
Externí odkaz:
https://doaj.org/article/0ec09dafb59745aaaaea06700fc8f38d
Autor:
Yung-Yu Hsieh, Shui-Yi Tung, Hung-Yu Pan, Chih-Wei Yen, Huang-Wei Xu, Yi-Fang Deng, Ying-Jhen Lin, Wan-Ting Hsu, Cheng-Shyong Wu, Chin Li
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background Gastric cancer is the eighth most common cancer in Taiwan, with a 40% 5-year survival rate. Approximately 40% of patients are refractory to chemotherapy. Currently, the anti-HER2 therapy is the only clinically employed targeted th
Externí odkaz:
https://doaj.org/article/6fd3f5cd07bd413f8be7298f4adbd3ed
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 28, Iss 12, Pp 641-648 (2012)
Liver stiffness measurement (LSM) is a noninvasive method for the diagnosis of hepatic fibrosis. The aim of this study was to evaluate the effects of hepatitis activity and antiviral therapy on LSM in cirrhotic patients. Consecutive patients with com
Externí odkaz:
https://doaj.org/article/1faa3745965a43868367902030617f9f
Autor:
Pei‐Kai Su, Te‐Sheng Chang, Shui‐Yi Tung, Kuo‐Liang Wei, Chien‐Heng Shen, Yung‐Yu Hsieh, Wei‐Ming Chen, Yi‐Hsing Chen, Chun‐Hsien Chen, Chih‐Wei Yen, Huang‐Wei Xu, Wei‐Ling Tung, Kao‐Chi Chang
Publikováno v:
Advances in Digestive Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b57ab629d208182e05ba1b9692fce24
https://doi.org/10.1002/aid2.13336
https://doi.org/10.1002/aid2.13336
Autor:
Shui-Yi Tung, Chi-Ching Chen, Kuo-Liang Wei, Chien-Heng Shen, Huang-Wei Xu, Sheng-Nan Lu, Chih-Wei Yen, Yi-Hsing Chen, Chao-Hung Hung, Te-Sheng Chang, Wei-Ming Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 119, Iss 1, Pp 532-537 (2020)
Background/Purpose: The major dose-limiting toxicity of ribavirin is hemolytic anemia. We investigated the incidence, risk factors and impact on virological response of anemia in chronic hepatitis C genotype 2 patients receiving sofosbuvir plus ribav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9220382bb767aee5e611b1642372217e
http://www.sciencedirect.com/science/article/pii/S0929664619304139
http://www.sciencedirect.com/science/article/pii/S0929664619304139
Autor:
Chien-Hung Chen, Chun-Hsun Yang, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Wei‐Ling Tung, Sheng-Nan Lu, Huang-Wei Xu, Po-Lin Tseng
Publikováno v:
Advances in Digestive Medicine. 7:30-35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1c420f8cbf59e6b40e21ac8eacb2cbb
https://doi.org/10.1002/aid2.13143
https://doi.org/10.1002/aid2.13143
Autor:
Huang-Wei Xu, Chi-Wei Yen, Chen-Heng Shen, Kao-Chi Chang, Wei-Lin Tung, Kuo-Liang Wei, Te-Sheng Chang, Yi-Hsing Chen, Chun-Hsien Chen, Yung-Yu Hsieh, Wei-Ming Chen, Sheng-Nan Lu, Chao-Hung Hung, Shui-Yi Tung
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Background/Purpose of StudyClinical trials have demonstrated excellent efficacy and safety of pangenotypic direct-acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV). However, there are limited large-scale real-world data on these p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9c2c09a77105629265fcb5eab23a041
https://pubmed.ncbi.nlm.nih.gov/34188161
https://pubmed.ncbi.nlm.nih.gov/34188161
Autor:
Chih-Wei Yen, Michelle Ong Chu, Huang-Wei Xu, Chao-Hung Hung, Chien-Heng Shen, Te-Sheng Chang, Sheng-Nan Lu
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports
Scientific Reports
The prognostic significance of various systemic inflammation‐based markers has been explored in different cancers after surgery. This study aimed to investigate whether these markers could predict outcomes in patients with early-stage hepatocellula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cb8c33f883cd04a89930d9e9edd1956
https://doi.org/10.1038/s41598-018-34543-z
https://doi.org/10.1038/s41598-018-34543-z